Skip to content
Open access · CC-BY via OpenAlex

Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

Jean Christopher Chamcheu, Tithi Roy, Mohammad B. Uddin, Sergette Banang‐Mbeumi, Roxane‐Cherille N. Chamcheu, Anthony L. Walker, Yu Liu, Shile Huang

Cells · 2019 · ▲ 212 citations

Abstract

The mammalian or mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) and associated phosphatidyl-inositiol 3-kinase (PI3K)/protein kinase B (Akt) pathways regulate cell growth, differentiation, migration, and survival, as well as angiogenesis and metabolism. Dysregulation of these pathways is frequently associated with genetic/epigenetic alterations and predicts poor treatment outcomes in a variety of human cancers including cutaneous malignancies like melanoma and non-melanoma skin cancers. Recently, the enhanced understanding of the molecular and genetic basis of skin dysfunction in patients with skin cancers has provided a strong basis for the development of novel therapeutic strategies for these obdurate groups of skin cancers. This review summarizes recent advances in the roles of PI3K/Akt/mTOR and their targets in the development and progression of a broad spectrum of cutaneous cancers and discusses the current progress in preclinical and clinical studies for the development of PI3K/Akt/mTOR targeted therapies with nutraceuticals and synthetic small molecule inhibitors.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/cells8080803
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Chamcheu, J.C., Roy, T., Uddin, M.B., Banang‐Mbeumi, S., Chamcheu, R.N., Walker, A.L., Liu, Y., &amp; Huang, S. (2019). Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. <em>Cells</em>. https://doi.org/10.3390/cells8080803
Vancouver
Chamcheu JC, Roy T, Uddin MB, Banang‐Mbeumi S, Chamcheu RN, Walker AL, et al. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. Cells. 2019. doi:10.3390/cells8080803.
BibTeX
@article{jean2019Rolean, title = {Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy}, author = {Jean Christopher Chamcheu and Tithi Roy and Mohammad B. Uddin and Sergette Banang‐Mbeumi and Roxane‐Cherille N. Chamcheu and Anthony L. Walker and Yu Liu and Shile Huang}, journal = {Cells}, year = {2019}, doi = {10.3390/cells8080803}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings